Azilsartan medoxomil
Showing 1 - 25 of 111
Essential Hypertension Trial (Azilsartan Medoxomil Potassium Tablet, Nifedipine Sustained -release Tablets, Levoamlodipine
Not yet recruiting
- Essential Hypertension
- Azilsartan Medoxomil Potassium Tablet
- +2 more
- (no location specified)
Jul 21, 2023
Azilsartan/Chlorthalidone and Irbesartan/Hydrochlorothiazide in
Completed
- Arterial Hypertension
-
Moscow, Russian FederationCity Hospital №5
Oct 14, 2020
Azilsartan Medoxomil in Treatment of Adult Essential
Recruiting
- Essential Hypertension
-
Goyang-si, Gyeonggi-do, Korea, Republic ofMyongji Hospital
Jul 17, 2020
Azilsartan Medoxomil/Chlorthalidone Fixed Dose Combination in
Recruiting
- Essential Hypertension
-
Nam-gu, Daegu, Korea, Republic ofYeungnam University Medical Center
Jul 21, 2020
Proteinuria, Kidney Dysfunction, Blood Pressure Trial in Hanzhou (Azilsartan, Losartan)
Recruiting
- Proteinuria
- +3 more
-
Hanzhou, Zhejiang, Chinathe Second Afficiated Hospital, Zhejiang University, School of M
Feb 22, 2023
Hypertension Trial in Worldwide (Azilsartan Medoxomil, Losartan, Placebo for Azilsartan Medoxomil)
Completed
- Hypertension
- Azilsartan Medoxomil
- +4 more
-
Anaheim, California
- +68 more
Feb 10, 2021
Hypertension, Atrial Fibrillation Trial in Beijing (Azilsartan or antihypertensive drugs other than ACEI, ARB or ARNI)
Not yet recruiting
- Hypertension
- Atrial Fibrillation
- Azilsartan or antihypertensive drugs other than ACEI, ARB or ARNI
-
Beijing, Beijing, ChinaBeijing Tsinghua Chang Gung Hospital
Apr 23, 2023
Azilsartan in Children From 6 to Less Than 16 Years Old With
Recruiting
- Hypertension
- Azilsartan (TAK-536)
-
Tokyo, JapanTakeda selected site
Mar 24, 2022
Healthy Volunteer Trial in Beijing (TAK-491, TAK-491 )
Completed
- Healthy Volunteer
- TAK-491
- TAK-491 placebo
-
Beijing, Beijing,P.R., China(unnamed)
Jan 28, 2020
Essential Hypertension, Type 2 Diabetes Trial in China, Taiwan, Thailand (Azilsartan Medoxomil)
Completed
- Essential Hypertension
- Type 2 Diabetes Mellitus
- Azilsartan Medoxomil
-
Hong Kong, Hong Kong, China
- +11 more
Oct 29, 2018
Health, Subjective Trial in Seoul (CTL0801 (Azilsartan), CTL0802 (Rosuvastatin), CTL0801 (Azilsartan) + CTL0802 (Rosuvastatin))
Completed
- Health, Subjective
- CTL0801 (Azilsartan)
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Dec 21, 2021
Essential Hypertension Trial in China (Azilsartan medoxomil, Valsartan, Azilsartan medoxomil Placebo)
Completed
- Essential Hypertension
- Azilsartan medoxomil
- +3 more
-
Beijing, Beijing, China
- +29 more
Feb 15, 2019
Healthy Trial in Mexico City (Chlorthalidone (HIGROTON® 50), Losartan (COZZAR®), A1+ A2 Co-administration of Chlorthalidone and
Completed
- Healthy
- Chlorthalidone (HIGROTON® 50)
- +3 more
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Oct 20, 2021
Hypertension Trial in Beijing (Azilsartan tablets, Azilsartan tablets, Olmesartan medoxomil tablets)
Completed
- Hypertension
- Azilsartan tablets
- +3 more
-
Beijing, ChinaPeking University First hospiatl
Aug 30, 2018
Pediatric Hypertension Trial in Japan (Azilsartan, Placebo)
Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino
Terminated
- Hypertension
- Amlodipine + Olmesartan medoxomil
-
San Fernando City, LA Union, Philippines
- +56 more
Jul 26, 2021
Bioequivalence of Two Azilsartan Formulations Trial in Hong Kong (Azilsartan (Zhaoke), Azilsartan (Takeda))
Completed
- Bioequivalence of Two Azilsartan Formulations
- Azilsartan (Zhaoke)
- Azilsartan (Takeda)
-
Hong Kong, Sha Tin New Territories, Hong KongPhase I Clinical Trial Centre, Chinese University of Hong Kong
Aug 28, 2018